iBio Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Discontinued Operations (Details)

Discontinued Operations (Details)					3 Months Ended		12 Months Ended
Discontinued Operations (Details)	May 31, 2024 USD ($) $ / shares shares	Mar. 30, 2023 USD ($)	Feb. 17, 2023 USD ($)	Nov. 03, 2022 USD ($)	Dec. 31, 2023 USD ($)	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($)	Jun. 30, 2023 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net proceeds from auctioned equipment							$ 116,000	$ 2,600,000
Loss recorded in discontinued operations							9,464,000	35,699,000
Fixed asset impairment charge							3,100,000	17,900,000
Inventory write-down to net realizable value								4,915,000
Gain on extinguishment of debt							808,000
iBio CDMO, LLC \| Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net proceeds from auctioned equipment							50,000	2,600,000
Percentage of workforce reduction				60.00%
Number of positions reduced				69
Pre-tax employee reduction expenses								1,900,000
Transition period for terminated employees				60 days
Loss recorded in discontinued operations							9,464,000	35,699,000
Fixed asset impairment charge							3,100,000	17,900,000
Inventory write-down to net realizable value								4,915,000
Personnel and severance costs								7,500,000
Interest charges on term note							1,149,000	900,000
Loss on sale of fixed assets							4,816,000	(773,000)
Gain on extinguishment of debt							808,000
iBio CDMO, LLC \| Discontinued Operations \| Fair Value, Nonrecurring \| Level 3
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Fixed asset impairment charge								17,900,000
iBio CDMO, LLC \| Discontinued Operations \| Facility \| Fair Value, Nonrecurring \| Level 3
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Fixed asset impairment charge					$ 3,100,000	$ 300,000		$ 6,300,000
iBio CDMO, LLC \| Discontinued Operations \| 2024 Purchase and Sale Agreement - The Board of Regents
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on sale of fixed assets							4,800,000
Gain on extinguishment of debt							800,000
iBio CDMO, LLC \| Discontinued Operations \| 2024 Purchase and Sale Agreement - The Board of Regents \| Facility
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on sale of fixed assets							$ 4,800,000
iBio CDMO, LLC \| Discontinued Operations \| The Auctioneers \| Auction Sale Agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Guaranteed minimum proceeds for auctioned equipment			$ 2,100,000
Net proceeds from auctioned equipment		$ 2,600,000
Final sale price for auctioned equipment		$ 2,900,000
Excess proceeds from auctioned equipment (percentage)		80.00%
Fees for auctioned equipment		$ 200,000
iBio CDMO, LLC \| Discontinued Operations \| Woodforest National Bank \| Settlement Agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of property paid to Woodforest to settle debt	$ 8,500,000
Cash payments to settle debt	$ 915,000
iBio CDMO, LLC \| Discontinued Operations \| Woodforest National Bank \| Settlement Agreement \| Pre-Funded Warrants
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Warrants issued to settle debt \| shares	1,560,570
Exercise price per share of warrants \| $ / shares	$ 0.0001